Soleno Therapeutics Inc (SLNO)

07:13 AM

Is Soleno Therapeutics Inc. a good long term investmentHigh-profit trading signals - PrintWeekIndia

07:13 AM

05:34 AM

Soleno Therapeutics Inc. Stock Analysis and ForecastFree Bull & Bear Market Updates - PrintWeekIndia

05:34 AM

Jul 24, 2025

What analysts say about Soleno Therapeutics Inc. stock outlookSuperior profit margins - jammulinksnews.com

Jul 24, 2025

Jul 24, 2025

What drives Soleno Therapeutics Inc. stock priceFree Investment Portfolio Suggestions - PrintWeekIndia

Jul 24, 2025

Jul 23, 2025

What analysts say about Soleno Therapeutics Inc. stockFree Risk Assessment Services - Autocar Professional

Jul 23, 2025

Jul 23, 2025

Can Soleno Therapeutics (SLNO) Climb 33.11% to Reach the Level Wall Street Analysts Expect? - Yahoo Finance

Jul 23, 2025

Jul 23, 2025

Here's What Could Help Soleno Therapeutics (SLNO) Maintain Its Recent Price Strength - Yahoo Finance

Jul 23, 2025

Jul 23, 2025

Soleno’s Rare Disease Drug Launch Turns Heads On Wall Street - Finimize

Jul 23, 2025

Jul 21, 2025

Soleno Therapeutics’ Vykat XR Exceeds Sales Expectations - MSN

Jul 21, 2025

Jul 19, 2025

Soleno gains as Betaville cites buyout interest (update) - MSN

Jul 19, 2025

Jul 18, 2025

(SLNO) Trading Report - news.stocktradersdaily.com

Jul 18, 2025

Jul 16, 2025

Soleno Therapeutics: A Strategic Capital Raise Balances M&A Optionality with Long-Term Growth Potential - AInvest

Jul 16, 2025

Jul 16, 2025

Soleno Therapeutics: Fairly Valued Despite M&A Expectations - Seeking Alpha

Jul 16, 2025

Jul 15, 2025

Soleno Therapeutics (SLNO) Receives a Buy from Oppenheimer - The Globe and Mail

Jul 15, 2025

Jul 14, 2025

Mintz Advises on Soleno Therapeutics’ $200 Million Public Offering - Mintz

Jul 14, 2025

Jul 13, 2025

Soleno Therapeutics Shares Dip Following $200 Million Stock Offering Pricing - MSN

Jul 13, 2025

Jul 12, 2025

Soleno Therapeutics stock dips on proposed $200M offering - MSN

Jul 12, 2025

Jul 12, 2025

Baird Maintains Soleno Therapeutics(SLNO.US) With Buy Rating, Raises Target Price to $121 - 富途牛牛

Jul 12, 2025

Jul 11, 2025

Stifel reiterates Buy rating on Soleno Therapeutics stock amid strong Vykat launch - Investing.com Nigeria

Jul 11, 2025

Jul 11, 2025

Stifel reiterates Buy rating on Soleno Therapeutics stock amid strong Vykat launch By Investing.com - Investing.com South Africa

Jul 11, 2025

Jul 11, 2025

Soleno Therapeutics Announces Public Stock Offering - TipRanks

Jul 11, 2025

Jul 11, 2025

In Brief: Soleno To Raise $200m To Boost Vykat XR Launch - insights.citeline.com

Jul 11, 2025

Jul 11, 2025

Soleno Therapeutics stock soars as Stifel reiterates Buy on strong Vykat sales - Investing.com Australia

Jul 11, 2025

Jul 11, 2025

Soleno Therapeutics prices $200M public offering - MSN

Jul 11, 2025

Jul 11, 2025

Baird raises Soleno Therapeutics stock price target to $121 on strong Vykat XR sales By Investing.com - Investing.com South Africa

Jul 11, 2025

Jul 11, 2025

Soleno Therapeutics Announces Pricing of $200 Million Public Offering of Common Stock - GlobeNewswire

Jul 11, 2025

Jul 10, 2025

Baird raises Soleno Therapeutics stock price target to $121 on strong Vykat XR sales - Investing.com Nigeria

Jul 10, 2025

Jul 10, 2025

Firm Advises Soleno Therapeutics on $200 Million Public Offering - Wilson Sonsini

Jul 10, 2025

Jul 10, 2025

Soleno reports preliminary Q2 revenue of $31-33 million for VYKAT XR - Investing.com Nigeria

Jul 10, 2025

Jul 10, 2025

Soleno Therapeutics Announces Proposed $200 Million Public Offering of Common Stock - GlobeNewswire

Jul 10, 2025

Jul 10, 2025

Soleno sales of new Prader-Willi drug rise faster than expected - BioPharma Dive

Jul 10, 2025

Jul 10, 2025

Soleno Therapeutics Prices $200 Mln Public Offering To Support VYKAT XR Launch - Nasdaq

Jul 10, 2025

Jul 10, 2025

Soleno Therapeutics stock falls after pricing $200 million offering By Investing.com - Investing.com Canada

Jul 10, 2025

Jul 10, 2025

Soleno Therapeutics stock falls after pricing $200 million offering - Investing.com

Jul 10, 2025